Baxter International’s largest manufacturing plant is back up to regular production levels nearly five months after it was ...

A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...

Key Takeaways Baxter International shares soared Thursday after the company's fourth-quarter results topped estimates.The ...

The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...

Baxter International on Thursday forecast 2025 profit above Wall Street estimates banking on strong sales of its medical devices, sending the company's shares up 7% in premarket trade.

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Baxter International ended 2024 on a positive note, overcoming challenges posed by Hurricane Helene and delivering better-than-expected Q4 results. The success of the Novum IQ infusion pump ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2024, and provided its financial guidance for first-quarter ...

Baxter International Inc (BAX) reports robust earnings growth and outlines strategic priorities for 2025 despite facing ...

Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...

Baxter's adjusted earnings per share from continuing operations came in at 58 cents, down from a year ago, but also beating projections. The results came as the company said Hurricane Helene ...